Journal of Molecular Medicine

, Volume 90, Issue 9, pp 997–1010 | Cite as

Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function

  • Ha Won Kim
  • Shujia Jiang
  • Muhammad Ashraf
  • Khawaja Husnain HaiderEmail author
Original Article


This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of PCMSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocytes through gap junctions. miR-210 expression in MSC was achieved by IPC or nanoparticle-based transfection of miR-210 plasmid (miRMSC) and functional recovery of the infarcted heart of rat transplanted with PCMSC or miRMSC was evaluated. Both PCMSC and miRMSC showed higher survival under lethal anoxia as compared to non-PCMSC and scramble-transfected MSC (ScMSC) controls with concomitantly lower CASP8AP2 expression. Similarly, both PCMSC and miRMSC survived better and accelerated functional recovery of ischemic heart post-transplantation. To validate our hypothesis that MSC deliver miR-210 to host cardiomyocytes, in vitro co-culture between cardiomyocytes and PCMSC or miRMSC (using non-PCMSC or ScMSC as controls) showed co-localization of miR-210 with gap-junctional connexin-43. miR-210 transfer to cardiomyocytes was blocked by heptanol pretreatment. Moreover, higher survival of cardiomyocytes co-cultured with PCMSC was observed with concomitant expression of CASP8AP2 as compared to cardiomyocytes co-cultured with non-PCMSC thus suggesting that miR-210 was translocated from MSC to protect host cardiomyocytes. Induction of miR-210 in MSC promoted their survival post-engraftment in the infarcted heart. Moreover, direct transfer of pro-survival miR-210 from miRMSC to host cardiomyocytes led to functional recovery of the ischemic heart.


Connexin-43 miR-210 Myocardium Preconditioning Stem cells 



This work was supported by NIH Grants# [R37 HL074272; HL-087246(M.A) and HL-087288; HL-089535; HL106190-01(Kh.H.H)].

Disclosure statement

Nothing to disclose.

Supplementary material

109_2012_920_MOESM1_ESM.pdf (4.3 mb)
ESM 1 (PDF 4436 kb)


  1. 1.
    Lau NC, Lim LP, Weinstein EG, Bartel DP (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294:858–862PubMedCrossRefGoogle Scholar
  2. 2.
    Rane S, Sayed D, Abdellatif M (2007) MicroRNA with a MacroFunction. Cell Cycle 6:1850–1855PubMedCrossRefGoogle Scholar
  3. 3.
    Semenza GL, Agani F, Feldser D, Iyer N, Kotch L, Laughner E, Yu A (2000) Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 475:123–130PubMedCrossRefGoogle Scholar
  4. 4.
    Ivan M, Harris AL, Martelli F, Kulshreshtha R (2008) Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med 12:1426–1431PubMedCrossRefGoogle Scholar
  5. 5.
    Haider KH, Kim HW, Ashraf M (2009) Hypoxia-inducible factor-1alpha in stem cell preconditioning: mechanistic role of hypoxia-related micro-RNAs. J Thorac Cardiovasc Surg 138:257PubMedCrossRefGoogle Scholar
  6. 6.
    Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davuluri RV, Ivan M (2007) Regulation of microRNA expression: the hypoxic component. Cell Cycle 6:1426–1431PubMedCrossRefGoogle Scholar
  7. 7.
    Fasanaro P, D’Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283:15878–15883PubMedCrossRefGoogle Scholar
  8. 8.
    Mathew LK, Simon MC (2009) mir-210: a sensor for hypoxic stress during tumorigenesis. Mol Cell 35:737–738PubMedCrossRefGoogle Scholar
  9. 9.
    Huang X, Le QT, Giaccia AJ (2010) MiR-210—micromanager of the hypoxia pathway. Trends Mol Med 16:230–237PubMedCrossRefGoogle Scholar
  10. 10.
    Lu G, Haider HK, Jiang S, Ashraf M (2009) Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 119:2587–2596PubMedCrossRefGoogle Scholar
  11. 11.
    Suzuki Y, Kim HW, Ashraf M, Haider H (2011) Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol 299:H1077–H1082CrossRefGoogle Scholar
  12. 12.
    Lu G, Jiang S., Ashraf, M., Haider, KH (2012) Sub-cellular preconditioning of stem cells: mitochondrial targeting of connexin-43 transgene is cytoprotective and involves shift of balance between mitochondrial Bak and Bcl-xL. Regen Med 7(3):323–334Google Scholar
  13. 13.
    Haider H, Ashraf M (2010) Preconditioning and stem cell survival. J Cardiovasc Transl Res 3:89–102PubMedCrossRefGoogle Scholar
  14. 14.
    Kim HW, Haider HK, Jiang S, Ashraf M (2009) Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 284:33161–33168PubMedCrossRefGoogle Scholar
  15. 15.
    Haider KH, Idris NM, Kim HW, Ahmed RP, Shujia J, Ashraf M (2010) MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts. Cardiovasc Res 88:168–178PubMedCrossRefGoogle Scholar
  16. 16.
    Ye L, Haider H, Tan R, Toh W, Law PK, Tan W, Su L, Zhang W, Ge R, Zhang Y et al (2007) Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation 116:I113–I120PubMedCrossRefGoogle Scholar
  17. 17.
    Chan SY, Loscalzo J (2010) MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9:1072–1083PubMedCrossRefGoogle Scholar
  18. 18.
    Zhu XM, Han T, Sargent IL, Yin GW, Yao YQ (2009) Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200(661):e1–e7PubMedGoogle Scholar
  19. 19.
    Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J (2008) hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14:1340–1348PubMedCrossRefGoogle Scholar
  20. 20.
    Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, Li C, O’Brien-Jenkins A, Katsaros D, Weber BL et al (2008) miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7:255–264PubMedCrossRefGoogle Scholar
  21. 21.
    Pulkkinen K, Malm T, Turunen M, Koistinaho J, Yla-Herttuala S (2008) Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 582:2397–2401PubMedCrossRefGoogle Scholar
  22. 22.
    Crosby ME, Kulshreshtha R, Ivan M, Glazer PM (2009) MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69:1221–1229PubMedCrossRefGoogle Scholar
  23. 23.
    Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F et al (2010) MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122:S124–S131PubMedCrossRefGoogle Scholar
  24. 24.
    Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611PubMedCrossRefGoogle Scholar
  25. 25.
    Valiunas V, Polosina YY, Miller H, Potapova IA, Valiuniene L, Doronin S, Mathias RT, Robinson RB, Rosen MR, Cohen IS et al (2005) Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol 568:459–468PubMedCrossRefGoogle Scholar
  26. 26.
    Kizana E, Cingolani E, Marban E (2009) Non-cell-autonomous effects of vector-expressed regulatory RNAs in mammalian heart cells. Gene Ther 16:1163–1168PubMedCrossRefGoogle Scholar
  27. 27.
    Hosoda T, Zheng H, Cabral-da-Silva M, Sanada F, Ide-Iwata N, Ogorek B, Ferreira-Martins J, Arranto C, D’Amario D, Del Monte F et al (2011) Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 123:1287–1296PubMedCrossRefGoogle Scholar
  28. 28.
    Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA, Greco SJ, Bryan M, Patel PS, Rameshwar P (2011) Gap junction-mediated import of microrna from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 71:1550–1560PubMedCrossRefGoogle Scholar
  29. 29.
    Barcaroli D, Bongiorno-Borbone L, Terrinoni A, Hofmann TG, Rossi M, Knight RA, Matera AG, Melino G, De Laurenzi V (2006) FLASH is required for histone transcription and S-phase progression. Proc Natl Acad Sci USA 103:14808–14812PubMedCrossRefGoogle Scholar
  30. 30.
    Milovic-Holm K, Krieghoff E, Jensen K, Will H, Hofmann TG (2007) FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J 26:391–401PubMedCrossRefGoogle Scholar
  31. 31.
    Kim HW, Mallick F, Durrani S, Ashraf M, Jiang S, Haider KH (2012) Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells. Antioxid Redox Signal. doi: 10.1089/ars.2012.4518

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Ha Won Kim
    • 1
  • Shujia Jiang
    • 1
  • Muhammad Ashraf
    • 1
  • Khawaja Husnain Haider
    • 1
    Email author
  1. 1.Department of PathologyUniversity of CincinnatiCincinnatiUSA

Personalised recommendations